Publications by authors named "Gabriel Garate"

Claim this Profile
P
Plasma with Added Protease Inhibitors Improves Alpha- and Beta-CGRP Measurement Compared to Serum: Towards a Reliable Biomarker for Chronic Migraine.
Lucía de la Guerra-Sasián, Gabriel Gárate, Jorge Madera, Sara Pérez-Pereda, Marta Pascual-Mato

Int J Mol Sci· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From Molecules to Models: miRNAs and Advanced Human Platforms of Neurodegeneration and Repair in Multiple Sclerosis.
María Muñoz-San Martín, Lucía de la Guerra-Sasián, Gabriel Gárate, Jorge Madera, Andrea González-Suárez

Int J Mol Sci· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low serum 25-hydroxyvitamin D levels in migraine are not related to headache frequency: A case-control study in patients with high-frequency/chronic migraine.
Marina Haro, Gabriel Gárate, José Luis Hernández, José Manuel Olmos, María Muñoz

Headache· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of Constipation in the Behavior of Circulating Alpha- and Beta-CGRP Levels in Chronic/High-Frequency Migraine Patients After CGRP Monoclonal Antibodies.
Gabriel Gárate, Marcos Polanco, Jorge Madera, María Muñoz-San Martín, Marta Pascual-Mato

Biomedicines· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Lessons with Fremanezumab as the Third Available CGRP Monoclonal Antibody in a Third-Level Hospital: Focus on the Factors Predicting Response.
Marcos Polanco, Gabriel Gárate, Julia Sánchez-Gudín, Jorge Madera, Julio Pascual

J Clin Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world.
Edoardo Caronna, Victor José Gallardo, Gabriella Egeo, Manuel Millán Vázquez, Candela Nieves Castellanos

J Neurol Neurosurg Psychiatry· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unravelling the role of beta-CGRP in inflammatory bowel disease and its potential role in gastrointestinal homeostasis.
Marta Pascual-Mato, Gabriel Gárate, Vicente González-Quintanilla, Beatriz Castro, María José García

BMC Gastroenterol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in circulating alpha-calcitonin gene-related peptide levels in inflammatory bowel disease and its relation to migraine comorbidity: A cross-sectional study.
Marta Pascual-Mato, Gabriel Gárate, Vicente González-Quintanilla, Jorge Madera-Fernández, Beatriz Castro

Headache· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Untangling the mess of CGRP levels as a migraine biomarker: an in-depth literature review and analysis of our experimental experience.
Gabriel Gárate, Julio Pascual, Marta Pascual-Mato, Jorge Madera, María Muñoz-San Martín

J Headache Pain· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased prevalence of migraine in women with inflammatory bowel disease: A cross-sectional study.
Marta Pascual-Mato, Gabriel Gárate, Carlota de Prado-Tejerina, María José García, Beatriz Castro

Cephalalgia· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on "Plasma calcitonin gene-related peptide and nerve growth factor as headache and pain biomarkers in recently deployed soldiers with and without a recent concussion".
Gabriel Gárate, Julio Pascual

Headache· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum Alpha and Beta-CGRP Levels in Chronic Migraine Patients Before and After Monoclonal Antibodies Against CGRP or its Receptor.
Gabriel Gárate, Vicente González-Quintanilla, Andrea González, Marta Pascual, Sara Pérez-Pereda

Ann Neurol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum alpha-CGRP levels are increased in COVID-19 patients with headache indicating an activation of the trigeminal system.
Gabriel Gárate, María Toriello, Vicente González-Quintanilla, Sara Pérez-Pereda, Jorge Madera

BMC Neurol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum Calcitonin Gene-Related Peptide α and β Levels are Increased in COVID-19 Inpatients.
Gabriel Gárate, Marta Pascual, Montserrat Rivero, María Toriello, Sara Pérez-Pereda

Arch Med Res· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increase in Serum Calcitonin Gene-Related Peptide β (CGRPβ) Levels in COVID-19 Patients with Diarrhea: An Underlying Mechanism?
Gabriel Gárate, Marta Pascual, José Manuel Olmos, Carmen Fariñas, Monserrat Rivero

Dig Dis Sci· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increase in CGRP levels in a case of hemicrania continua normalizes after a successful response to galcanezumab.
Gabriel Gárate, Sara Pérez Pereda, Vicente González-Quintanilla, Jorge Madera, Julio Pascual

Neurol Sci· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis